SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Jeffrey Bland, PhD, chief science officer for Metagenics, Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, has been awarded the 2011 Nutrition Business Journal’s (NBJ) Education award for his expertise and contributions to international nutritional medicine education. The NBJ awards give recognition to the industry’s influential leaders who have made a significant impact in the fields of health, wellness and nutrition.
“I am honored to receive the Nutrition Business Journal’s Education award,” said Dr. Bland. “Educating healthcare practitioners in the science of nutrigenomics is the key to reversing the tide of chronic illness that is currently overwhelming our healthcare system worldwide. As more and more practitioners and patients discover the power of lifestyle medicine to achieve life-long health, we are at the tipping point of shifting our focus from treating disease to creating health.”
For more than 25 years, Dr. Bland has been an internationally recognized leader in the nutritional medicine field. A nutritional biochemist, he is a prominent researcher and educator for the science of nutrigenomics, the study of how nutritive substances and phytochemicals affect genetic expression within human cells.
Dr. Bland currently serves as the chief science officer for Metagenics and is the president of Metagenics’ wholly-owned subsidiary, MetaProteomics Nutrigenomics Research Center. His scientific team has published more than 80 peer-reviewed articles and been awarded more than 50 international or domestic patents. Their research is the foundation for Metagenics’ industry-leading products and programs that reduce chronic illness and improve health.
In addition to lecturing and teaching on nutrigenomics around the world, Dr. Bland leads and shapes hundreds of educational programs offered through Metagenics University, including the certification programs for First Line Therapy (FLT), a personalized lifestyle program centered on therapeutic lifestyle change.
Dr. Bland’s leadership in nutrigenomics education also includes achievements such as:
- Professor of biochemistry at the University of Puget Sound.
- Director of nutritional research at the Linus Pauling Institute of Science and Medicine.
- First member of the board of trustees of Bastyr University, the first federally accredited university in the United States offering graduate and undergraduate degrees in natural medicine. Dr. Bland contributed significantly to its founding and accreditation.
- Establishment of the Institute of Functional Medicine to educate clinicians about functional medicine.
- President at the Northwest Academy of Preventive Medicine
- Author of the textbook, The Medical Applications of Clinical Nutrition, that has been used in numerous medical and graduate school curriculums
Dr. Bland will be publicly honored for his outstanding achievements in nutrition medicine education at the 15th annual NBJ Summit in Dana Point, California, on July 24-27.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company focused on reversing chronic illness and improving health. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in San Clemente, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium, and Brisbane, Australia.